Rosiglitazone

Rosiglitazone is a thiazolidinedione and active pharmaceutical ingredient that acts as a PPARγ agonist to improve insulin sensitivity. Mediocon Inc supplies high-purity Rosiglitazone API conforming to IP / BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.

Rosiglitazone enhances peripheral glucose uptake by activating peroxisome proliferator-activated receptor gamma (PPARγ), improving insulin sensitivity in adipose tissue, skeletal muscle, and the liver. It is used in the management of type 2 diabetes mellitus.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Type 2 diabetes mellitus management
• Insulin sensitizer formulations
• PPARγ agonist pharmaceutical research
• Antidiabetic oral dosage forms

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings